Literature DB >> 16531794

Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.

Josep Redón1, Luis Cea-Calvo, José V Lozano, Cristina Fernández-Pérez, Jorge Navarro, Alvaro Bonet, Jorge González-Esteban.   

Abstract

BACKGROUND AND OBJECTIVES: Epidemiological data on the incidence and prevalence of cardiovascular disease in chronic renal failure are scant The objective of the present study is to assess the relationship between renal function, measured by the estimated glomerular filtration rate, and the presence of early or established cardiovascular disease, in a population of hypertensives from primary care. PATIENTS AND METHODS: Cross-sectional, multicentre study carried out in primary care centres all over Spain. Hypertensive subjects, older than 55 years, were included. In all of them a structured interview including cardiovascular risk factors or disease was performed. Blood pressure was measured following a standard procedure, and serum biochemistry and an electrocardiogram were obtained. Renal function was estimated using the abbreviated MDRD (Modification of Diet in Renal Disease Study Group) equation. For each glomerular filtration rate stratum the odds ratio and 95% confidence interval (CI) of left ventricular hypertrophy or cardiovascular disease were calculated, adjusted by confounding variables.
RESULTS: A total of 13 687 patients (mean age 68.1 years, women 55.4%, diabetics 30.6%, body mass index 28.6 kg/m2) were included. Of these, 26.4% had established cardiovascular diseases and 20.3% electrocardiographic left ventricular hypertrophy. The average serum creatinine was 1.01 mg/dl, creatinine clearance 70.0 ml/min, and glomerular filtration rate 74.0 ml/min per 1.73 m2. Thirty-three patients (0.24%) had glomerular filtration rate < 5 ml/min per 1.73 m2; 89 (0.65%) from 15 to 29; 3745 (27.36%) from 30 to 59; 7798 (56.97%) from 60 to 89; and 2019 (14.75%) higher than 89 ml/min per 1.73 m2. In a multiple regression analysis, after adjusting by age, sex, body mass index, diabetes, systolic and diastolic blood pressure, and smoking, a lower glomerular filtration rate was associated with a higher prevalence of left ventricular hypertrophy. Likewise, a reduction in the glomerular filtration rate was also associated with a higher prevalence of cardiovascular disease.
CONCLUSIONS: In hypertensive patients from primary care, the prevalence of cardiovascular disease is inversely proportional to the level of renal function. Estimated glomerular filtration is easy to determine and complements evaluation of the hypertensive patient.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16531794     DOI: 10.1097/01.hjh.0000217848.10831.5f

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  9 in total

1.  Improved blood pressure control in elderly hypertensive patients: results of the PAPY-65 Survey.

Authors:  Patricia Van der Niepen; Alain G Dupont
Journal:  Drugs Aging       Date:  2010-07-01       Impact factor: 3.923

2.  Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease.

Authors:  Rajiv Agarwal; Robert P Light
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-18       Impact factor: 8.237

3.  Chronic kidney disease in patients with diabetes mellitus type 2 or hypertension in general practice.

Authors:  Victor van der Meer; H Petra M Wielders; Diana C Grootendorst; Joost S de Kanter; Yvo Wj Sijpkens; Willem Jj Assendelft; Jacobijn Gussekloo; Friedo W Dekker; Ymte Groeneveld
Journal:  Br J Gen Pract       Date:  2010-12       Impact factor: 5.386

4.  Prevalence of reduced renal function among diabetic hypertensive patients.

Authors:  Waleed M Sweileh; Ansam F Sawalha; Sa'ed H Zyoud; Samah W Al-Jabi1; Nasr Y Shraim
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2008-11-20

5.  [Prevalence of chronic kidney disease in hypertensive patients under treatment at primary care health centres in Spain and the monitoring of their blood pressure: the DISEHTAE Study].

Authors:  Luis Vara-González; Enrique Martín Rioboó; Tomás Ureña Fernández; Antoni Dalfó Baqué; Isabel Flor Becerra; Vicente López Fernández
Journal:  Aten Primaria       Date:  2008-05       Impact factor: 1.137

6.  Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study.

Authors:  Luis Cea-Calvo; Pedro Conthe; Pablo Gómez-Fernández; Fernando de Alvaro; Cristina Fernández-Pérez
Journal:  Cardiovasc Diabetol       Date:  2006-11-03       Impact factor: 9.951

Review 7.  Pathophysiology of the cardio-renal syndromes types 1-5: An uptodate.

Authors:  L Di Lullo; A Bellasi; V Barbera; D Russo; L Russo; B Di Iorio; M Cozzolino; C Ronco
Journal:  Indian Heart J       Date:  2017-01-22

8.  Guideline adherence in cardiovascular risk assessment and analysis in 15,000 hypertensive German patients in real life: results of the Prospective 3A Registry.

Authors:  Ralf Dechend; Edelgard Kaiser; Wolfgang Derer; Evelin Deeg; Andreas Busjahn; Roland E Schmieder; Uwe Zeymer
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-31       Impact factor: 3.738

9.  Association between renal function and cardiovascular disease in patients with left ventricular hypertrophy. VIIDA study.

Authors:  Lorenzo Fácila; Vicente Bertomeu; Vicente Bertomeu-González; Pedro Morillas; Pilar Mazón; Jose R González-Juanatey
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-06       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.